Previous 10 | Next 10 |
Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United Kingdom Company's validated test available in the UK following implementation of UKHSA CTDA Regulations PR Newswire SALT LAKE CITY , Nov. 4, 2021 /PRNewswire/ -- ...
Co-Diagnostics, Inc. Announces Third Quarter 2021 Earnings Release Date And Webcast PR Newswire SALT LAKE CITY , Oct. 28, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the devel...
Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for Dengue/Chikungunya Multiplex Test PR Newswire SALT LAKE CITY , Oct. 6, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a uniq...
Co-Diagnostics, Inc. to Introduce At Home/Point of Care Device at AACC on Sept 28 In addition to hosting a booth to promote its existing diagnostics products at the conference, the Company will also hold a press conference to introduce its upcoming at-home and point-of-care PCR ...
Co-Diagnostics, Inc. Announces Corporate Rebranding Following Period of Transformative Growth and Expansion PR Newswire SALT LAKE CITY , Sept. 23, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a...
Co-Diagnostics, Inc. to Present at ACTC Liquid Biopsy Conference in Kalamata, Greece PR Newswire SALT LAKE CITY , Sept. 21, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented p...
Co-Diagnostics, Inc. Logix Smart™ ABC Test Authorized for Use in Mexico PR Newswire SALT LAKE CITY , Sept. 21, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the developme...
Presentation Times and Weblinks Released for Over 130 Presenting Companies Wednesday and Thursday, September 22 - 23, 2021 NEW YORK, NY / ACCESSWIRE / September 21, 2021 / Sidoti & Company, LLC proudly releases the presentation schedule, with weblink click-throughs, for its Si...
Co-Diagnostics, Inc. to Present at Sidoti Virtual Investor Conference PR Newswire SALT LAKE CITY , Sept. 20, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) a molecular diagnostics company with a unique, patented platform for the development of molecular...
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for Chikungunya and Dengue Tests PR Newswire SALT LAKE CITY , Sept. 16, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, p...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...